Retatrutide, a triple-target receptor agonist, is similar to semaglutide
CAS Number 2381089-83-2
Formula C223H343F3N46O70
Molar mass 4845.444 g·mol−1
Retatrutide (LY-3437943) is a triple hormone receptor agonist for GLP-1, GIP and GCGR receptors. In a phase 2 trial, the study showed that its use reduced body weight by more than 17.5% in overweight and pre-diabetic adults. The ingredient is a peptide with the amino acid sequence YA1QGTFTSDYSIL2LDKK4AQA1AFIEYLLEGGPSGAPPS3.
Semaglutide (single target)
Tirzepatide (dual target)
Retatrutide (triple target)
Our company can provide custom peptide class
